These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31235258)

  • 1. Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke.
    Huang L; Wang J; Huang S; Siaw-Debrah F; Nyanzu M; Zhuge Q
    Biochem Biophys Res Commun; 2019 Aug; 516(2):565-570. PubMed ID: 31235258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles.
    Ma YH; Wu SY; Wu T; Chang YJ; Hua MY; Chen JP
    Biomaterials; 2009 Jul; 30(19):3343-51. PubMed ID: 19299010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion.
    Deng J; Mei H; Shi W; Pang ZQ; Zhang B; Guo T; Wang HF; Jiang XG; Hu Y
    Curr Med Sci; 2018 Jun; 38(3):427-435. PubMed ID: 30074208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
    Niessen F; Hilger T; Hoehn M; Hossmann KA
    Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
    Chen HA; Ma YH; Hsu TY; Chen JP
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
    Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
    Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
    Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.
    Liu R; Liu Q; He S; Simpkins JW; Yang SH
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1006-12. PubMed ID: 19952306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a carotid artery thrombolysis stroke model in mice.
    Maclean JAA; Tomkins AJ; Sturgeon SA; Hofma BR; Alwis I; Samson AL; Schoenwaelder SM; Jackson SP
    Blood Adv; 2022 Sep; 6(18):5449-5462. PubMed ID: 35767737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.
    Peng T; Booher K; Moody MR; Yin X; Aronowski J; McPherson DD; Savitz SI; Kim H; Huang SL
    Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
    J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
    Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.
    Tiebosch IA; Crielaard BJ; Bouts MJ; Zwartbol R; Salas-Perdomo A; Lammers T; Planas AM; Storm G; Dijkhuizen RM
    J Neurochem; 2012 Nov; 123 Suppl 2():65-74. PubMed ID: 23050644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
    Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
    Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator.
    Huang Y; Han Z; Shen T; Zheng Y; Yang Z; Fan J; Wang R; Yan F; Tao Z; Luo Y; Liu P
    CNS Neurosci Ther; 2024 Jul; 30(7):e14825. PubMed ID: 38954749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.